NCT02085148 2024-04-22
A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy
Bayer
Phase 1 Completed
Bayer
Italian Sarcoma Group
Italian Sarcoma Group
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)